Flavobacterium meningosepticum ventriculitis: In vivo and in vitro results with the combinations rifampicin-erythromycin and mezlocillin-cefoxitin
| Autor: | A. M. Emmerson, Y. Drabu, M. C. Kelsey |
|---|---|
| Rok vydání: | 1982 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty Erythromycin Microbial Sensitivity Tests Penicillins Pharmacology Flavobacterium Microbiology Cerebral Ventricles Cefoxitin Medical microbiology In vivo polycyclic compounds Ventriculitis medicine Humans Mezlocillin biology Infant Bacterial Infections General Medicine biochemical phenomena metabolism and nutrition bacterial infections and mycoses medicine.disease biology.organism_classification Anti-Bacterial Agents Infectious Diseases Encephalitis Drug Therapy Combination Female Rifampin Rifampicin medicine.drug |
| Zdroj: | European Journal of Clinical Microbiology. 1:138-143 |
| ISSN: | 1435-4373 0722-2211 |
| Popis: | A case of Flavobacterium meningosepticum ventriculitis is described in which the failure of therapy with a combination of rifampicin and erythromycin is attributed to inadequate antibiotic levels in cerebrospinal fluid. The successful eradication of the organism was achieved with the use of mezlocillin and cefoxitin given by the intravenous and intraventricular route. In vitro sensitivity tests of recently isolated strains of Flavobacterium meningosepticum suggested that the combination mezlocillin and cefoxitin is more often synergistic than rifampicin and erythromycin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink